by
Thomas Dworetzky, Contributing Reporter | March 13, 2020
"Sitting at the center of healthcare, helping manage more than $61 billion in healthcare spend, Premier serves as an early warning system for the supply chain," said Premier’s president, Michael J. Alkire. He stated that the survey results were sent to the FDA and CDC to help them better understand the coronavirus situation.
In late February the release of U.S. stockpiles of N95 filtering face-piece respirators that were beyond their shelf life was examined by the CDC.
Ad Statistics
Times Displayed: 19090
Times Visited: 362 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
The agency found that, based on preliminary information “many models have continued to perform in accordance with NIOSH performance standards. Accordingly, CDC/NIOSH believes the following products, despite being past their manufacturer-designated shelf life, should provide the expected level of protection to the user if the stockpile conditions have generally been in accordance with the manufacturer-recommended storage conditions and an OSHA-compliant respiratory protection program is used by employers. In alphabetical order, these models are:
3M 1860
3M 1870
3M 8210
3M 9010
3M 8000
Gerson 1730
Medline/Alpha Protech NON27501
Moldex 1512
Moldex 2201
The agency noted that “in times of increased demand and decreased supply, consideration can be made to use the N95s listed above past their manufacturer-designated shelf life when responding to COVID-19.”
Back to HCB News
